Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Otiprio Versus Ciprodex to Reduce Tympanostomy Tube Failure

NCT03347461 is registered in ClinicalTrials.gov with Boston Medical Center as lead sponsor.

NCT NCT03347461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03347461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Otiprio Versus Ciprodex to Reduce Tympanostomy Tube Failure
Lead sponsor
Boston Medical Center
Phase
Phase 4
Overall status
Withdrawn
Start date
October 31, 2018
Completion date
June 30, 2019
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

otitis media with effusion in children, otorrhea